Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Anthony Fernando | President, CEO & Director | 804.69k | -- | 1972 |
| Mr. Shameze Rampertab B.Sc. MBA, CA, CPA | Executive VP & CFO | 475.31k | -- | 1967 |
| Mr. Joshua B. Weingard | Chief Legal Officer & Secretary | -- | -- | 1973 |
| Mr. Ethan Loiselle | Vice President of Global Marketing | -- | -- | -- |
| Ms. Amanda Owens | Vice President of People | -- | -- | -- |
| Mr. Ravi Kommineni | Head of Global Quality & Regulatory | -- | -- | -- |
| Mr. Motti Frimer | Vice President of R&D, Digital Solutions and MD of Asensus Surgical | -- | -- | -- |
Asensus Surgical, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 207
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
Corporate Governance
Upcoming Events
August 8, 2024 at 10:59 AM UTC - August 12, 2024 at 12:00 PM UTC
Asensus Surgical, Inc. Earnings Date
Recent Events
March 12, 2024 at 8:40 PM UTC
at Oppenheimer Healthcare MedTech & Services Conference (Virtual)